Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
Case ReportBrain

Ipilimumab-Induced Hypophysitis: MR Imaging Findings

K.J. Carpenter, R.D. Murtagh, H. Lilienfeld, J. Weber and F.R. Murtagh
American Journal of Neuroradiology October 2009, 30 (9) 1751-1753; DOI: https://doi.org/10.3174/ajnr.A1623
K.J. Carpenter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R.D. Murtagh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Lilienfeld
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Weber
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F.R. Murtagh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 30 no. 9 1751-1753
DOI 
https://doi.org/10.3174/ajnr.A1623
PubMed 
19474123

Published By 
American Journal of Neuroradiology
Print ISSN 
0195-6108
Online ISSN 
1936-959X
History 
  • Received February 19, 2009
  • Accepted after revision March 19, 2009
  • Published online October 8, 2009.

Article Versions

  • Latest version (May 27, 2009 - 06:44).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © American Society of Neuroradiology

Author Information

  1. K.J. Carpentera,
  2. R.D. Murtagha,b,c,
  3. H. Lilienfeldd,
  4. J. Webere and
  5. F.R. Murtagha,b,c
  1. aFrom the Department of Radiology (K.J.C., R.D.M., F.R.M.), University of South Florida, Tampa, Fla
  2. bUniversity Diagnostic Institute (R.D.M., F.R.M,), Tampa, Fla
  3. cDepartments of Diagnostic Imaging and Interdisciplinary Oncology (R.D.M., F.R.M.)
  4. dEndocrinology (H.L.)
  5. eCutaneous Surgery (J.W.), Moffitt Cancer Center and Research Institute, Tampa, Fla.
  1. Please address correspondence to Ryan D. Murtagh, MD, MBA, University Diagnostic Institute, 3301 Alumni Dr, Tampa FL 33629; e-mail: rmurtagh13{at}gmail.com
View Full Text

Altmetrics

Cited By...

  • 81 Citations
  • 84 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
    Anne Bertrand, Marie Kostine, Thomas Barnetche, Marie-Elise Truchetet, Thierry Schaeverbeke
    BMC Medicine 2015 13 1
  • Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies
    David J. Byun, Jedd D. Wolchok, Lynne M. Rosenberg, Monica Girotra
    Nature Reviews Endocrinology 2017 13 4
  • Endocrine Side Effects Induced by Immune Checkpoint Inhibitors
    Salvatore Maria Corsello, Agnese Barnabei, Paolo Marchetti, Liana De Vecchis, Roberto Salvatori, Francesco Torino
    The Journal of Clinical Endocrinology & Metabolism 2013 98 4
  • Ipilimumab and Its Toxicities: A Multidisciplinary Approach
    Leslie A. Fecher, Sanjiv S. Agarwala, F. Stephen Hodi, Jeffrey S. Weber
    The Oncologist 2013 18 6
  • Radiologic Manifestations of Immune-Related Adverse Events in Patients With Metastatic Melanoma Undergoing Anti–CTLA-4 Antibody Therapy
    Yulia Bronstein, Chaan S. Ng, Patrick Hwu, Wen-Jen Hwu
    American Journal of Roentgenology 2011 197 6
  • Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma
    Frédérique Albarel, Caroline Gaudy, Frédéric Castinetti, Tiphaine Carré, Isabelle Morange, Bernard Conte-Devolx, Jean-Jacques Grob, Thierry Brue
    European Journal of Endocrinology 2015 172 2
  • Imaging of Cancer Immunotherapy: Current Approaches and Future Directions
    Mizuki Nishino, Hiroto Hatabu, F. Stephen Hodi
    Radiology 2019 290 1
  • Immune-Mediated Adverse Events Associated with Ipilimumab CTLA-4 Blockade Therapy: The Underlying Mechanisms and Clinical Management
    Ahmad Tarhini
    Scientifica 2013 2013
  • Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports
    Meng H. Tan, Ravi Iyengar, Kara Mizokami-Stout, Sarah Yentz, Mark P. MacEachern, Li Yan Shen, Bruce Redman, Roma Gianchandani
    Clinical Diabetes and Endocrinology 2019 5 1
  • MECHANISMS IN ENDOCRINOLOGY: Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review
    A. Juszczak, A. Gupta, N. Karavitaki, M. R. Middleton, A. B. Grossman
    European Journal of Endocrinology 2012 167 1
  • Cancer immunotherapy and immune-related response assessment: The role of radiologists in the new arena of cancer treatment
    Mizuki Nishino, Sree H. Tirumani, Nikhil H. Ramaiya, F. Stephen Hodi
    European Journal of Radiology 2015 84 7
  • Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1
    Ahmed Mekki, Laurent Dercle, Philip Lichtenstein, Aurélien Marabelle, Jean-Marie Michot, Olivier Lambotte, Jérôme Le Pavec, Eleonora De Martin, Corinne Balleyguier, Stéphane Champiat, Samy Ammari
    European Journal of Cancer 2018 96
  • ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses
    Francesco Torino, Agnese Barnabei, Rosa Maria Paragliola, Paolo Marchetti, Roberto Salvatori, Salvatore Maria Corsello
    European Journal of Endocrinology 2013 169 6
  • The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management
    Monica Girotra, Aaron Hansen, Azeez Farooki, David J Byun, Le Min, Ben C Creelan, Margaret K Callahan, Michael B Atkins, Elad Sharon, Scott J Antonia, Pamela West, Amy E Gravell
    JNCI Cancer Spectrum 2018 2 3
  • Immune Checkpoint Inhibitor Cancer Therapy: Spectrum of Imaging Findings
    Gary X. Wang, Vikram Kurra, Justin F. Gainor, Ryan J. Sullivan, Keith T. Flaherty, Susanna I. Lee, Florian J. Fintelmann
    RadioGraphics 2017 37 7
  • Imaging of tumour response to immunotherapy
    Clarisse Dromain, Catherine Beigelman, Chiara Pozzessere, Rafael Duran, Antonia Digklia
    European Radiology Experimental 2020 4 1
  • Ipilimumab treatment associated pituitary hypophysitis: Clinical presentation and imaging diagnosis
    Yosef Chodakiewitz, Sanford Brown, Jerrold L. Boxerman, Jeffrey M. Brody, Jeffrey M. Rogg
    Clinical Neurology and Neurosurgery 2014 125
  • Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know)
    R. M. Ruggeri, A. Campennì, G. Giuffrida, P. Trimboli, L. Giovanella, F. Trimarchi, S. Cannavò
    Journal of Endocrinological Investigation 2019 42 7
  • Cancer immunotherapy-induced endocrinopathies: Clinical behavior and therapeutic approach
    Pedro Iglesias
    European Journal of Internal Medicine 2018 47
  • Cancer immunotherapy-associated hypophysitis
    Cinzia Solinas, Michele Porcu, Pushpamali De Silva, Marco Musi, Sandrine Aspeslagh, Mario Scartozzi, Karen Willard-Gallo, Stefano Mariotti, Luca Saba
    Seminars in Oncology 2018 45 3
  • A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors
    Neeraj Chhabra, Joseph Kennedy
    Journal of Medical Toxicology 2021 17 4
  • Brain tumour post-treatment imaging and treatment-related complications
    Alexander T. Kessler, Alok A. Bhatt
    Insights into Imaging 2018 9 6
  • Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database
    Julie Garon-Czmil, Nadine Petitpain, Franck Rouby, Marion Sassier, Samy Babai, Mélissa Yéléhé-Okouma, Georges Weryha, Marc Klein, Pierre Gillet
    Scientific Reports 2019 9 1
  • Frequency and imaging features of abdominal immune-related adverse events in metastatic lung cancer patients treated with PD-1 inhibitor
    Francesco Alessandrino, Sonia Sahu, Mizuki Nishino, Anika E. Adeni, Sree Harsha Tirumani, Atul B. Shinagare, Mark M. Awad
    Abdominal Radiology 2019 44 5
  • Practical Management of Immune-Related Adverse Events from Immune Checkpoint Protein Antibodies for the Oncologist
    Jeffrey S. Weber
    American Society of Clinical Oncology Educational Book 2012 32
  • Detection of Early Onset of Hypophysitis by 18F-FDG PET-CT in a Patient With Advanced Stage Melanoma Treated With Ipilimumab
    Bernies van der Hiel, Christian U. Blank, John B.A.G. Haanen, Marcel P.M. Stokkel
    Clinical Nuclear Medicine 2013 38 4
  • Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know
    Marta Braschi-Amirfarzan, Sree Harsha Tirumani, Frank Stephen Hodi, Mizuki Nishino
    Korean Journal of Radiology 2017 18 1
  • Ipilimumab, not just another anti-cancer therapy: hypophysitis as side effect illustrated by four case-reports
    Joke Marlier, Veronique Cocquyt, Lieve Brochez, Simon Van Belle, Vibeke Kruse
    Endocrine 2014 47 3
  • Complications of Targeted Drug Therapies for Solid Malignancies: Manifestations and Mechanisms
    Richard G. Abramson, Vandana G. Abramson, Emily Chan, Leora Horn, Vicki L. Keedy, William Pao, Jeffrey A. Sosman
    American Journal of Roentgenology 2013 200 3
  • Neuroimaging of central diabetes insipidus—when, how and findings
    N. C. Adams, T. P. Farrell, A. O’Shea, A. O’Hare, J. Thornton, S. Power, P. Brennan, S. Looby
    Neuroradiology 2018 60 10
  • Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series
    T. Lam, M. M. K. Chan, A. N. Sweeting, S. M. C. De Sousa, A. Clements, M. S. Carlino, G. V. Long, K. Tonks, E. Chua, R. F. Kefford, D. R Chipps
    Internal Medicine Journal 2015 45 10
  • Machine learning defined diagnostic criteria for differentiating pituitary metastasis from autoimmune hypophysitis in patients undergoing immune checkpoint blockade therapy
    Ahmed Mekki, Laurent Dercle, Philip Lichtenstein, Ghaida Nasser, Aurélien Marabelle, Stéphane Champiat, Emilie Chouzenoux, Corinne Balleyguier, Samy Ammari
    European Journal of Cancer 2019 119
  • Multimodality imaging of endocrine immune related adverse events: a primer for radiologists
    Francesco Alessandrino, Hina J. Shah, Nikhil H. Ramaiya
    Clinical Imaging 2018 50
  • Insights into non-classic and emerging causes of hypopituitarism
    Flavia Prodam, Marina Caputo, Chiara Mele, Paolo Marzullo, Gianluca Aimaretti
    Nature Reviews Endocrinology 2021 17 2
  • Cancer immunotherapy-associated hypophysitis
    Franklin Castillero, Omar Castillo-Fernández, Geiner Jiménez-Jiménez, José Fallas-Ramírez, Marco P Peralta-Álvarez, Oscar Arrieta
    Future Oncology 2019 15 27
  • Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events
    Remo Poto, Teresa Troiani, Gjada Criscuolo, Giancarlo Marone, Fortunato Ciardiello, Carlo Gabriele Tocchetti, Gilda Varricchi
    Frontiers in Immunology 2022 13
  • Ipilimumab in the treatment of melanoma
    Van A. Trinh, Wen-Jen Hwu
    Expert Opinion on Biological Therapy 2012 12 6
  • Autoimmune hypophysitis: expanding the differential diagnosis to CTLA-4 blockade
    Angelika Gutenberg, Melissa Landek-Salgado, Shey-Cherng Tzou, Isabella Lupi, Abby Geis, Hiroaki Kimura, Patrizio Caturegli
    Expert Review of Endocrinology & Metabolism 2009 4 6
  • Focal Immunotherapy-Induced Pancreatitis Mimicking Metastasis on FDG PET/CT
    Jeeban Paul Das, Darragh Halpenny, Richard K. Do, Gary A. Ulaner
    Clinical Nuclear Medicine 2019 44 10
  • Imaging findings of immune checkpoint inhibitor associated pancreatitis
    Jeeban P. Das, Michael A. Postow, Claire F. Friedman, Richard K. Do, Darragh F. Halpenny
    European Journal of Radiology 2020 131
  • Overview and management of toxicities associated with systemic therapies for advanced renal cell carcinoma
    Anh Pham, Da-Wei Ye, Sumanta Pal
    Urologic Oncology: Seminars and Original Investigations 2015 33 12
  • Ipilimumab Therapy for Melanoma: A Mimic of Leptomeningeal Metastases
    S. Ali, S.-K. Lee
    American Journal of Neuroradiology 2015 36 12
  • Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not)
    Salvatore Maria Corsello, Roberto Salvatori, Agnese Barnabei, Liana De Vecchis, Paolo Marchetti, Francesco Torino
    Cancer Chemotherapy and Pharmacology 2013 72 2
  • Hypophysitis induced by immune checkpoint inhibitors in a Scottish melanoma population
    Khor Zhong Wei, Mark Baxter, Richard Casasola
    Melanoma Management 2019 6 1
  • Immune-related adverse events on body CT in patients with small-cell lung cancer treated with immune-checkpoint inhibitors
    Hyesun Park, Hiroto Hatabu, Biagio Ricciuti, Safiya J. Aijazi, Mark M. Awad, Mizuki Nishino
    European Journal of Radiology 2020 132
  • MRI Findings of Immune Checkpoint Inhibitor–Induced Hypophysitis: Possible Association with Fibrosis
    R. Kurokawa, Y. Ota, W. Gonoi, A. Hagiwara, M. Kurokawa, H. Mori, E. Maeda, S. Amemiya, Y. Usui, N. Sato, Y. Nakata, T. Moritani, O. Abe
    American Journal of Neuroradiology 2020
  • Nivolumab–induced encephalitis post allogeneic stem cell transplant in a patient with Hodgkin’s disease
    Alejandro De la Hoz, Farnaz Foolad, Cinthia Gallegos, Steven Kornblau, Dimitrios P. Kontoyiannis
    Bone Marrow Transplantation 2019 54 5
  • A review of the imaging manifestations of immune check point inhibitor toxicities
    Richard Thomas, Bibin Sebastian, Tom George, Noor Fatima Majeed, Temilola Akinola, Shawn L. Laferriere, Marta Braschi-Amirfarzan
    Clinical Imaging 2020 64
  • Endocrinopatías autoinmunitarias inducidas por anticuerpos inmunomoduladores en el tratamiento del cáncer
    Pedro Iglesias, Ainara Soria, Juan José Díez
    Medicina Clínica 2015 145 6
  • Ipilimumab cystic hypophysitis mimicking metastatic melanoma
    John Wallace, Martin Krupa, James Brennan, Frank Mihlon
    Radiology Case Reports 2018 13 3
  • Preoperative differentiation of hypophysitis and pituitary adenomas using a novel clinicoradiologic scoring system
    Kyla Wright, Hyon Kim, Travis Hill, Matthew Lee, Cordelia Orillac, Nikita Mogar, Donato Pacione, Nidhi Agrawal
    Pituitary 2022 25 4
  • Anticytotoxic T-Lymphocyte Antigen-4 Induced Autoimmune Hypophysitis: A Case Report and Literature Review
    Deborah Majchel, Mary T. Korytkowski
    Case Reports in Endocrinology 2015 2015
  • Chemotherapy, Immunotherapy, and Psychotropic Use in Cancer Patients: A Review of Psychiatric Side Effects
    Natalie Kurkjian, Phebe Tucker, Britta Ostermeyer, Alan Valentine
    Psychiatric Annals 2017 47 4
  • Ipilimumab-Induced Secondary Hypophysitis
    Arvinder Cheema
    Endocrine Practice 2018 24 9
  • Ipilimumab-induced autoimmune hypophysitis: a differential for sellar mass lesions
    Beverly T Rodrigues, Zulfiquer Otty, Kunwarjit Sangla, Vasant V Shenoy
    Endocrinology, Diabetes & Metabolism Case Reports 2014 2014
  • Late-onset hypophysitis after discontinuation of nivolumab treatment for advanced skin melanoma: a case report
    Sofia Antoniou, Georgios Bazazo, Ludwig Röckl, Marios Papadakis, Christian Berg
    BMC Endocrine Disorders 2021 21 1
  • MRT-Veränderungen bei Immunmodulation
    K. Guggenberger, H. Urbach
    Der Nervenarzt 2018 89 8
  • The Pituitary
    Luis V. Syro, Fabio Rotondo, Olga Moshkin, Kalman Kovacs
    2017
  • Checkpoint Inhibitor Immune-Related Adverse Events: A Multimodality Pictorial Review
    Kathleen M. Capaccione, Jacienta P. Valiplackal, Alice Huang, Tina Roa, Alana Fruauff, Connie Liou, Eleanor Kim, Sakshi Khurana, Mary Maher, Hong Ma, Pamela Ngyuen, Serena Mak, Shifali Dumeer, Sonali Lala, Belinda D'souza, Sherelle Laifer-Narin, Elise Desperito, Carrie Ruzal-Shapiro, Mary M. Salvatore
    Academic Radiology 2022 29 12
  • Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 2. Neoplasms other than PitNET and tumor-mimicking lesions
    Taro Tsukamoto, Yukio Miki
    Japanese Journal of Radiology 2023
  • Magnetic resonance imaging criteria of immune checkpoint inhibitor-induced hypophysitis
    Ayman Nada, Roopa Bhat, Joseph Cousins
    Current Problems in Cancer 2021 45 1
  • Overview of imaging findings associated with systemic therapies in advanced epithelial ovarian cancer
    Ezgi Guler, Daniel A. Smith, Bhanusupriya Somarouthu, Rahul Gujrathi, Nikhil H. Ramaiya, Sree Harsha Tirumani
    Abdominal Radiology 2020 45 3
  • The Pituitary
    Marcel Maya, Barry D. Pressman
    2017
  • 64-Year-Old Man With Altered Mental Status
    Tyler J. Schmidt, Yosuf W. Subat, Alice Gallo De Moraes
    Mayo Clinic Proceedings 2020 95 9
  • Cancer Immunotherapy
    Margaret K. Callahan, Michael A. Postow, Jedd D. Wolchok
    2013
  • Hypophysitis related to immune checkpoint inhibitors: An intriguing adverse event with many faces
    Maria V Deligiorgi, Charis Liapi, Dimitrios T Trafalis
    Expert Opinion on Biological Therapy 2021 21 8
  • Ipilimumab (Immune Checkpoint Inhibitors) Hypophysitis
    Margot Stagnetto, Patrick Mailleux
    Journal of the Belgian Society of Radiology 2020 104 1
  • Ipilimumab-Induced Hypophysitis
    Muhammad Usama, Tanveer Mir, Ania Fida, Syed Umer Mohsin, Hammad Ali, Fazal I. Raziq, Muhammad Shayan Khan, Diane Levine
    American Journal of Therapeutics 2021 28 6
  • Pituitary enlargement following ipilimumab without long term endocrine dysfunction
    Edson Nogueira, Arjun Menon, Anastasia Dede, Indu Mitra, Cathryn Brock, James Larkin, Daniel Morganstein
    Current Problems in Cancer 2021 45 6
  • The Human Hypothalamus - Neuroendocrine Disorders
    Terence Patrick Farrell, Niamh Catherine Adams, Seamus Looby
    2021 181
  • Therapy Response Imaging in Oncology
    Peter Abraham, Jason Handwerker
    2020
  • Autoimmune endocrinopathies induced by immunomodulating antibodies in the treatment of cancer
    Pedro Iglesias, Ainara Soria, Juan José Díez
    Medicina Clínica (English Edition) 2015 145 6
  • Autoimmune hypophysitis in a patient successfully treated with anti-ctla-4 (Ipilimumab) immunotherapy for metastatic malignant melanoma
    R.A. Sutton, M. Voskoboynik, G.A. McArthur, J. Lokan
    Pathology 2013 45
  • Current awareness: Pharmacoepidemiology and drug safety
    Pharmacoepidemiology and Drug Safety 2010 19 5
  • Emergency Imaging of At-Risk Patients
    Carlos Zamora, Mauricio Castillo, Paulo Puac-Polanco, Carlos Torres
    2023
  • Endocrine Emergencies
    Monica Girotra
    2022
  • Expected and non-expected immune-related adverse events detectable by CT
    Federica Ciccarese, Alberto Piccinino, Stefano Brocchi, Caterina Balacchi, Filippo Gustavo Dall’Olio, Francesco Massari, Karim Rihawi, Alexandro Paccapelo, Andrea Ardizzoni, Rita Golfieri
    European Journal of Radiology 2021 138
  • Functional Imaging of Immunotherapy: Response Criteria, Imaging Characteristics, and Novel Immunoimaging of Advanced Malignancies
    Roxanna D. Juarez, Andrew Taliaferro, Spencer C. Behr
    Current Radiology Reports 2020 8 11
  • Neuroimaging Pharmacopoeia
    Daniel Thomas Ginat, Gul Moonis
    2022
  • Neuroimaging Pharmacopoeia
    Daniel Thomas Ginat, Gul Moonis
    2015
  • Neurological Complications of Systemic Cancer and Antineoplastic Therapy
    John Vincent Murray, Richard Douglas Beegle, Sean Dodson
    2022
  • Prevalence of Symptomatic Nonstenotic Carotid Disease Using Simultaneous Non-Contrast Angiography and Intraplaque Hemorrhage Imaging for MR Screen Protocol
    Chae Rin Lee, Jun Cheol Yang, Ui Yun Lee, Seung Bae Hwang, Gyung Ho Chung, Hyo Sung Kwak
    Diagnostics 2022 12 10
  • Radiological Imaging of Adverse Events to Immunotherapy
    E. I. Zyablova, L. N. Nefedova, V. A. Porkhanov
    Journal of oncology: diagnostic radiology and radiotherapy 2020 3 3
  • Silverberg's Principles and Practice of Surgical Pathology and Cytopathology
    Sylvia L. Asa
    2015
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 30 (9)
American Journal of Neuroradiology
Vol. 30, Issue 9
1 Oct 2009
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ipilimumab-Induced Hypophysitis: MR Imaging Findings
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Ipilimumab-Induced Hypophysitis: MR Imaging Findings
K.J. Carpenter, R.D. Murtagh, H. Lilienfeld, J. Weber, F.R. Murtagh
American Journal of Neuroradiology Oct 2009, 30 (9) 1751-1753; DOI: 10.3174/ajnr.A1623

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Ipilimumab-Induced Hypophysitis: MR Imaging Findings
K.J. Carpenter, R.D. Murtagh, H. Lilienfeld, J. Weber, F.R. Murtagh
American Journal of Neuroradiology Oct 2009, 30 (9) 1751-1753; DOI: 10.3174/ajnr.A1623
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • Case Reports
    • Discussion
    • Conclusions
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • MRI Findings of Immune Checkpoint Inhibitor-Induced Hypophysitis: Possible Association with Fibrosis
  • Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy
  • Ipilimumab Therapy for Melanoma: A Mimic of Leptomeningeal Metastases
  • Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma
  • ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses
  • Neurological immune-related adverse events of ipilimumab
  • Ipilimumab and Its Toxicities: A Multidisciplinary Approach
  • MECHANISMS IN ENDOCRINOLOGY: Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review
  • Crossref (84)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
    Anne Bertrand, Marie Kostine, Thomas Barnetche, Marie-Elise Truchetet, Thierry Schaeverbeke
    BMC Medicine 2015 13 1
  • Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies
    David J. Byun, Jedd D. Wolchok, Lynne M. Rosenberg, Monica Girotra
    Nature Reviews Endocrinology 2017 13 4
  • Endocrine Side Effects Induced by Immune Checkpoint Inhibitors
    Salvatore Maria Corsello, Agnese Barnabei, Paolo Marchetti, Liana De Vecchis, Roberto Salvatori, Francesco Torino
    The Journal of Clinical Endocrinology & Metabolism 2013 98 4
  • Ipilimumab and Its Toxicities: A Multidisciplinary Approach
    Leslie A. Fecher, Sanjiv S. Agarwala, F. Stephen Hodi, Jeffrey S. Weber
    The Oncologist 2013 18 6
  • Radiologic Manifestations of Immune-Related Adverse Events in Patients With Metastatic Melanoma Undergoing Anti–CTLA-4 Antibody Therapy
    Yulia Bronstein, Chaan S. Ng, Patrick Hwu, Wen-Jen Hwu
    American Journal of Roentgenology 2011 197 6
  • Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma
    Frédérique Albarel, Caroline Gaudy, Frédéric Castinetti, Tiphaine Carré, Isabelle Morange, Bernard Conte-Devolx, Jean-Jacques Grob, Thierry Brue
    European Journal of Endocrinology 2015 172 2
  • Imaging of Cancer Immunotherapy: Current Approaches and Future Directions
    Mizuki Nishino, Hiroto Hatabu, F. Stephen Hodi
    Radiology 2019 290 1
  • Immune-Mediated Adverse Events Associated with Ipilimumab CTLA-4 Blockade Therapy: The Underlying Mechanisms and Clinical Management
    Ahmad Tarhini
    Scientifica 2013 2013
  • Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports
    Meng H. Tan, Ravi Iyengar, Kara Mizokami-Stout, Sarah Yentz, Mark P. MacEachern, Li Yan Shen, Bruce Redman, Roma Gianchandani
    Clinical Diabetes and Endocrinology 2019 5 1
  • MECHANISMS IN ENDOCRINOLOGY: Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review
    A. Juszczak, A. Gupta, N. Karavitaki, M. R. Middleton, A. B. Grossman
    European Journal of Endocrinology 2012 167 1

More in this TOC Section

  • Usefulness of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson Disease
  • White Matter Alterations in the Brains of Patients with Active, Remitted, and Cured Cushing Syndrome: A DTI Study
  • Qualitative and Quantitative Analysis of MR Imaging Findings in Patients with Middle Cerebral Artery Stroke Implanted with Mesenchymal Stem Cells
Show more BRAIN

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2022 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2023 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire